Meta-analysis: Assocation between promoter hypermethylation of dapk (death-associated protein kinase) and cervical cancer

Abstract

Purpose: Death-associated protein kinase (DAPK or DAPK1) is an important tumor suppressor protein that involved in the regulation of cell activities. The aberrant methylation of DAPK promoter has been reported in patients with cervical cancer. However, the association between of DAPK 1 and cervical cancer was not always unification, in previous studies. Therefore, in current study, a meta-analysis was performed for association of between DAPK gene's promoter hypermcthylated and cervical cancer. Methods: A systematic literature analysis was conducted based on the previous studies published in PubMed, PubMed Central (NCBI), Google by using following keywords: cervical cancer, cervical carcinoma, Méthylation, by the end of January, 2018. The association between DAPK promoter méthylation and cervical cancer was evaluated by odds ratio (ORs) and 95% confidence intervals (CT). To evaluate the potential sources of heterogeneity, the meta-regression analysis and subgroup analysis were conducted. Results: A total of 21 case-control studies which relevant to Lhe association between DAPK1 gene's promoter méthylation frequency and cervical cancer, that including 1600 cancer cases and 1011 control cases (non-cancerous cases). The analysis results indicated that the characteristic of candidate gene’s promoter méthylation increased the cervical cancer risk through the calculation of OR value (OR = 21.25; 95% Cl - 8.73 - 52,97; p < 0.001; Random effect model). The association between DAPK1 gene’s promoter hyperméthylation was confirmed in all the subgroups analyses, including materials and assays methods, ethnicity. Furthermore, this association is higher in cervical squamous cell carcinoma than cervical adenocarcinoma and is a characteristic of late-stage disease. Conclusion: The hypermcthylated DAPK1 gene’s promoter was also one of etiological factor, lead to the cervical tumorigenesis.